Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS
Open accessThe DOI matches its Crossref record; 68 of the 70 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
The field of non-pharmacological therapies for treatment resistant depression (TRD) is rapidly evolving and new somatic therapies are valuable options for patients who have failed numerous other treatments. A major challenge for clinicians (and patients alike) is how to integrate the results from published clinical trials in the clinical decision-making process.We reviewed the literature for articles reporting results for clinical trials in particular efficacy data, contraindications and side effects of somatic therapies including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), vagal nerve stimulation (VNS) and deep brain stimulation (DBS). Each of these devices has an indication for patients with different level of treatment resistance, based on acuteness of illness, likelihood of response, costs and associated risks. ECT is widely available and its effects are relatively rapid in severe TRD, but its cognitive adverse effects may be cumbersome. TMS is safe and well tolerated, and it has been approved by FDA for adults who have failed to respond to one antidepressant, but its use in TRD is still controversial as it is not supported by rigorous double-blind randomized clinical trials. The options requiring surgical approach are VNS and DBS. VNS has been FDA-approved for TRD, however it is not indicated for management of acute illness. DBS for TRD is still an experimental area of investigation and double-blind clinical trials are underway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatments with enhanced spatial specificity such as deep brain stimulation (DBS) or transcranial magnetic stimulation (TMS), aimed to restore region-specific hypoactivity, show great promise in alleviating treatment-resistant depression in even the most severe cases (2–10).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“1% lifetime incidence, and is associated with a high rate of morbidity and mortality [1].”
BackgroundNON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460 · cited 1×
“Transcranial magnetic stimulation (TMS) was introduced in 1985 as a technique to stimulate the cerebral cortex non-invasively [6].”
MethodMayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416 · cited 1×
“Subcingulate –Broadmann area 25 (SCG 25) Mayberg and colleagues have demonstrated the integral role of the subgenual cingulate cortex in both normal and pathological shifts in mood [50].”
BackgroundO’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910 · cited 1×
“Subjects were randomly assigned to either active (n = 155) or sham TMS (n = 146) conditions [21].”
Method(2003) · The Lancet · doi:10.1016/s0140-6736(03)12705-5 · Cited by 1,706 · cited 1×
“efficacy of ECT in TRD is well established, with 60% to 90% rate of acute response in TRD [3], and it is indicated specifically in severe psychotic depression, catatonia and delirious mania.”
Background(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 2×
“” Since then, one large NIMH-sponsored, multicenter, randomized, sham-controlled study has been conducted [26], and this trial showed a statistically significant difference between the treatments, but overall low rates for both response and remission.”
BackgroundMethodDeep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027 · cited 1×
“NAC In 2008, Schlaepfer and colleagues described bilateral implantation in the shell and core of the NAC in 3 patients with TRD [64].”
BackgroundSubcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression
Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., & Kennedy, S. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.034 · Cited by 1,024 · cited 1×
“SCG25 The early open-label study recruited 20 patients [59] with an MDE and a level of treatment-resistance of 4 or 5.”
BackgroundDeep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Rauch, S. L., Rasmussen, S. A., Machado, A. G., Kubu, C. S., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.029 · Cited by 897
Self-citation
Research works printed but not linked: 1
- Burke WJ, Moreno FA: Suicidality in treatment-resistant depression: results from a 24-month trial of vagus nerve stimulation. Proceedings of 156th American Psychiatric Association Annual Meeting. 2006, Toronto. Canada: May 20-25
Cited by
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230
Pharmacological approaches to the challenge of treatment-resistant depression
Ionescu, D. F., Rosenbaum, J. F., & Alpert, J. E. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.2/dionescu · Cited by 212
Affective Brain–Computer Interfaces (aBCIs): A Tutorial
Wu, D., Lu, B., Hu, B., & Zeng, Z. (2023) · Proceedings of the IEEE · doi:10.1109/jproc.2023.3277471 · Cited by 151
Coenen, V. A., Schumacher, L. V., Kaller, C., Schlaepfer, T. E., Reinacher, P. C., Egger, K., Urbach, H., & Reisert, M. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.03.019 · Cited by 127
“Moreover, noninvasive therapies like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) exert their therapeutic effects by possibly affecting very similar prefrontal regions (Cusin & Dougherty, 2012), opening the road for more personalized and focal interventions.”
Metadata
- Authors
- Cusin, C., & Dougherty, D. D.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Cusin, Cristina
- Venue
- Biology of Mood & Anxiety Disorders
- Published
- 2012-08-17
- Volume
- 2
- Issue
- 1
- Pages
- 14-14
- ISSN
- 2045-5380 (ISSN-L)
- PMC
- PMC3514332
- OpenAlex
- W2148550679
- Cited by
- 98
- References
- 69
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 9 · 2023: 14 · 2022: 15 · 2021: 3 · 2020: 3 · 2019: 9 · 2018: 10 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 8 · 2013: 4
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-01-01)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Biology of Mood & Anxiety Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- treatment-resistant depression, somatic therapy, electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation, non-pharmacological treatment, cognitive side effects, treatment selection, clinical decision-making
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. https://app.cochat.ai/papers/10.1186/2045-5380-2-14
- The paper
- Cusin, C., & Dougherty, D. D. (2012). Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biology of Mood & Anxiety Disorders. https://doi.org/10.1186/2045-5380-2-14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.